EP 0633784 B1 19961227 - Hepatitis vaccins containing 3-0 deacylated monophosphoryl lipid A
Title (en)
Hepatitis vaccins containing 3-0 deacylated monophosphoryl lipid A
Title (de)
3-0-deacyliertes Monophosphoryl-Lipid-A enthaltende Hepatitis-Impfstoffe
Title (fr)
Vaccins anti-hépatite contenant du monophosphoryl-lipide A 3-0-désacylé
Publication
Application
Priority
- EP 9300712 W 19930324
- GB 9206786 A 19920327
- GB 9206788 A 19920327
- GB 9206789 A 19920327
- GB 9206797 A 19920327
Abstract (en)
[origin: WO9319780A1] A vaccine formulation for the treatment or prophylaxis of hepatitis, especially hepatitis B, infections is provided comprising the hepatitis antigen and a suitable carrier such as alum in combination with 3-O-deacylated monophosphoryl lipid A. Combination vaccines including the vaccine formulation are also described.
IPC 1-7
IPC 8 full level
A61K 39/39 (2006.01); A61K 36/00 (2006.01); A61K 39/29 (2006.01); A61K 39/295 (2006.01); A61K 47/36 (2006.01); A61K 47/44 (2006.01); A61P 31/12 (2006.01)
IPC 8 main group level
A61K 38/00 (2006.01); G01N 33/00 (2006.01)
CPC (source: EP KR)
A61K 39/12 (2013.01 - EP); A61K 39/29 (2013.01 - EP KR); A61K 39/292 (2013.01 - EP); A61K 39/295 (2013.01 - KR); A61K 39/39 (2013.01 - EP); A61P 1/16 (2017.12 - EP); A61P 31/12 (2017.12 - EP); A61K 2039/5252 (2013.01 - EP); A61K 2039/55505 (2013.01 - EP); A61K 2039/55572 (2013.01 - EP); A61K 2039/70 (2013.01 - EP); C12N 2730/10134 (2013.01 - EP); C12N 2770/32434 (2013.01 - EP); Y02A 50/30 (2017.12 - EP)
Citation (examination)
K R Myers et al., "a critical determinant of lipid A endotoxic activity", in "Cellular and molecular aspects of endotoxin reactions"; A Novotny, JJ Spitzer, EJ Ziegler, Editors; 1990, pages 145-56.
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9319780 A1 19931014; AP 570 A 19961129; AP 9300502 A0 19930430; AT E146678 T1 19970115; AU 1000802 A 20020221; AU 3397499 A 19990819; AU 3751693 A 19931108; AU 6445796 A 19961107; AU 767755 B2 20031120; CA 2132833 A1 19931014; CA 2132833 C 20070306; CN 1072963 C 20011017; CN 1085805 A 19940427; CZ 235594 A3 19950215; CZ 283424 B6 19980415; DE 69306940 D1 19970206; DE 69306940 T2 19970626; DE 69306940 T3 20020919; DK 0633784 T3 19970120; DK 0633784 T4 20011231; EP 0633784 A1 19950118; EP 0633784 B1 19961227; EP 0633784 B2 20011017; ES 2098029 T3 19970416; ES 2098029 T5 20020316; FI 110843 B 20030415; FI 944442 A0 19940926; FI 944442 A 19940926; GR 3022174 T3 19970331; HK 1003218 A1 19981016; HU 221253 B1 20020928; HU 9402758 D0 19941228; HU T69931 A 19950928; IL 105161 A0 19930708; IL 105161 A 19980816; JP 3470719 B2 20031125; JP H07505372 A 19950615; KR 100270134 B1 20001016; KR 950700757 A 19950220; MA 22842 A1 19931001; MY 111880 A 20010228; NO 309458 B1 20010205; NO 943571 D0 19940926; NO 943571 L 19941114; NZ 249868 A 19970324; RU 2121849 C1 19981120; RU 94042386 A 19960820; SA 93130573 B1 20040831; SG 48375 A1 19980417; SI 9300149 A 19931231; SI 9300149 B 20030228; SK 115294 A3 19950607; SK 280160 B6 19990910; UA 44688 C2 20020315
DOCDB simple family (application)
EP 9300712 W 19930324; AP 9300502 A 19930325; AT 93906601 T 19930324; AU 1000802 A 20020102; AU 3397499 A 19990610; AU 3751693 A 19930324; AU 6445796 A 19960905; CA 2132833 A 19930324; CN 93105232 A 19930326; CZ 235594 A 19930324; DE 69306940 T 19930324; DK 93906601 T 19930324; EP 93906601 A 19930324; ES 93906601 T 19930324; FI 944442 A 19940926; GR 960403615 T 19961230; HK 98102341 A 19980319; HU 9402758 A 19930324; IL 10516193 A 19930325; JP 51704693 A 19930324; KR 19940703355 A 19940927; MA 23137 A 19930323; MY PI19930533 A 19930323; NO 943571 A 19940926; NZ 24986893 A 19930324; RU 94042386 A 19930324; SA 93130573 A 19930608; SG 1996009183 A 19930324; SI 9300149 A 19930326; SK 115294 A 19930324; UA 94105947 A 19930324